E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/25/2008 in the Prospect News PIPE Daily.

New Issue: Nastech plans $7.93 million direct offering of shares, warrants

By Devika Patel

Knoxville, Tenn., April 25 - Nastech Pharmaceutical Co. Inc. said it has arranged a $7.93 million direct offering of stock and warrants.

The company will sell 4,585,260 common shares at $1.73 per share.

The investors also will receive seven-year warrants, for 4,585,260 common shares, exercisable at $2.38. In addition, the investors have the right to purchase up to 1,375,578 common shares at $2.17 per share during the 90-day period beginning Oct. 25.

Proceeds will be used for working capital. Settlement is expected on April 25.

Nastech is a Bothell, Wash., pharmaceutical company.

Issuer:Nastech Pharmaceutical Co. Inc.
Issue:Common stock, warrants
Amount:$7,932,500
Shares:4,585,260
Price:$1.73
Warrants:For 4,585,260 shares
Warrant expiration:Seven years
Warrant strike price:$2.38
Pricing date:April 25
Settlement date:April 25
Stock symbol:Nasdaq: NSTK
Stock price:$2.18 at close April 24

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.